In This Section

Program

Please note that this meeting will take place as an in-person event in Philadelphia and will not live-stream content for virtual participation. The meeting content will be recorded and made available as an on-demand program after the conference. Please see the registration page for details.

CME credit is available for in-person attendance for the designated sessions. On-demand presentations are not eligible for CME.

All presentations are scheduled to be live, in-person presentations at the date and time specified below unless noted otherwise. Program in progress.

*-Short talk from proffered abstract

Wednesday, June 19

Thursday, June 20

Friday, June 21

Saturday, June 22

Wednesday, June 19

REGISTRATION
3:30-8:30 P.M.

WELCOME AND OPENING Keynote lecture
6-7 P.M.
CME-Eligible

  • Welcome and Introduction of Keynote Speaker
    Michael R. Green, The University of Texas MD Anderson Cancer Center, Houston, Texas
  • Keynote Lecture
    Metabolic regulation of lymphoma development
    Tak W. Mak, UHN Princess Margaret Cancer Centre, Toronto, ON, Canada

Plenary Session 1: Signaling/immune synapse
7-8:45 P.M.
CME-Eligible

Session Chair: Francesco Bertoni, Institute of Oncology Research, Bellinzona, Switzerland

  • Oncogenic signaling in T-cell and B-cell lymphoma
    Jürgen Ruland, Technical University of Munich, Munich, Germany
  • Lymphoma immune microenvironment shaping receptivity to various immunological therapeutic strategies
    Roberta Zappasodi, Weill Cornell Medicine, New York, New York
  • BTK inhibitor resistance
    Francesco Bertoni

OPENING RECEPTION
8:45-10:15 P.M.

Thursday, June 20

CONTINENTAL BREAKFAST
7:30-8:30 A.M.

spotlight on proffered papers session
8:30-9:55 A.M.
CME-Eligible

break
9:55-10:15 A.M.

PLENARY SESSION 2: Germinal Center Biology and its Role in Lymphomagenesis
10:15 a.m.-12 P.m.
CME-Eligible

Session Chair: Coraline Mlynarczyk, Weill Cornell Medicine, New York, New York

  • Jayanta Chaudhuri, Memorial Sloan Kettering Cancer Center, New York, New York
  • Competition in the germinal center
    Coraline Mlynarczyk
  • T-cell dependent acquisition of stem-like plasticity in Germinal Center B cells
    Effie Apostolou, Weill Cornell Medicine, New York, New York

Free time/lunch on own
12-1:30 p.m.

Plenary Session 3: Premalignant Processes in Lymphomagenesis
1:30-3:15 P.M.
CME-Eligible

Session Chair: Jagan Muppidi, National Cancer Institute, Bethesda, Maryland

  • Lymphoid clonal hematopoiesis
    Aswin Sekar, Dana-Farber Cancer Institute, Boston, Massachusetts
  • Spontaneous germinal centers and lymphoma hallmark lesions
    Jagan Muppidi
  • Expanded clones of T cells with lymphoma driver mutations in unexplained cases of refractory celiac disease
    Mandeep Singh, Garvin Institute of Medical Research, Sydney, Australia

Break
3:15-3:35 P.M.

Plenary Session 4: Lymphoma Clonal Precursors and Transformation
3:35-5:20 P.M.
CME-Eligible

Session Chair: Ari M. Melnick, Weill Cornell Medical College / Cornell University, New York, New York

  • Ari M. Melnick
  • Deciphering and intercepting follicular lymphoma clonal precursor cells
    Sandrine Roulland, Aix-Marseille University, Marseille, France
  • Transformation to aggressive lymphoma: Molecular basis and detection
    Erin M. Parry, Dana-Farber Cancer Institute, Boston, Massachusetts

Poster session/reception
5:30-7:30 P.m.

Friday, June 21

CONTINENTAL BREAKFAST
7:30-8:30 A.M.

Plenary Session 5: Lymphoma Etiology and Outcomes: The Role of Age and Ethnicity
8:30-10:15 A.M.
CME-Eligible

Session Chair: Christopher R. Flowers, The University of Texas MD Anderson Cancer Center, Houston, Texas

  • The etiology of pediatric lymphoma
    Lisa G. Roth, Weill Cornell Medicine, New York, New York
  • An aged/autoimmune origin to B cell lymphomas
    Leandro Venturutti, BC Cancer, Vancouver, BC, Canada
  • Disparities in lymphoma
    Christopher R. Flowers

break
10:15-10:35 A.M.

Plenary Session 6: Lymphoma Epigenetics
10:35 a.m.-12:15 P.M.
CME-Eligible

Session Chair: Michael R. Green, The University of Texas MD Anderson Cancer Center, Houston, Texas

  • Steven M. Horwitz, Memorial Sloan Kettering Cancer Center, New York, New York
  • Laura Pasqualucci, Columbia University, New York, New York
  • Perturbation of cell state transitions by epigenetic mutations
    Michael R. Green

Free time/lunch on own
12:15-1:45 p.m.

Plenary Session 7: Lymphoma Microenvironment / Tumor Immunology of Lymphoma
1:45-3:30 P.M.
CME-Eligible

Session Chair: Margaret A. Shipp, Dana Farber Cancer Institute, Boston, Massachusetts

  • Bispecific antibodies in lymphoma therapy
    Martin Hutchings, Copenhagen University Hospital, Copenhagen, Denmark
  • The lymphoma microenvironment
    Margaret A. Shipp
  • Multi-omic profiling of the follicular lymphoma tumor microenvironment
    Andrea J. Radtke, National Institute of Allergy and Infectious Disease, Bethesda, Maryland

Break
3:30-3:50 P.M.

Plenary Session 8: New Approaches in CAR T-cell Therapy
3:30-5:30 P.M.
CME-Eligible

Session Chair: Michel Sadelain, Memorial Sloan Kettering Cancer Center, New York, New York

  • New approaches to CAR T-cell therapy
    Michel Sadelain
  • Clonotype-specific CAR T
    Marco Ruella, University of Pennsylvania, Philadelphia, PA
  • How to make CART cells work in spite of lymphoma immune evasion mechanisms
    Joshua D. Brody, Icahn School of Medicine at Mount Sinai, New York, New York

Evening off
5:30 p.m.

Saturday, June 22

CONTINENTAL BREAKFAST
7-8 A.M.

keynote lecture
8-9 A.M.
CME-Eligible

  • Keynote Lecture
    Ash A. Alizadeh, Stanford University, Stanford, California

Plenary Session 9: Chemo-free Approaches to Lymphoma
9-10:45 a.m.
CME-Eligible

Session Chair: Jason Westin, The University of Texas MD Anderson Cancer Center, Houston, Texas

  • Jason Westin
  • Targeted treatment of DLBCL
    Wyndham H. Wilson, National Cancer Institute, Bethesda, Maryland
  • Rewiring cancer drivers to activate apoptosis
    Gerald R. Crabtree, Stanford University, Stanford, California

break
10:45-11 A.M.

Plenary Session 10: Bringing Genomics from Bench to Bedside
11 A.M.-12:45 p.m.
CME-Eligible

  • Precision therapy based on somatic mutation profiles
    H. Christian Reinhardt, Essen University Hospital, Essen, Germany
  • T-cell lymphoma molecular classifications that inform therapy
    Catalina Amador, University of Miami Miller School of Medicine, Miami, Florida
  • Genetic subtype-guided immunochemotherapy in DLBCL
    Wei-Li Zhao, Ruijin Hospital, Shanghai, China

Departure
12:45 p.m.